Q4 2024 Cresco Labs Inc Earnings Call Transcript
Key Points
- Cresco Labs Inc (CRLBF) generated $724 million in revenue for 2024, maintaining adjusted gross profit dollars flat despite a slight year-over-year decline.
- The company improved its adjusted EBITDA by $26 million, reaching $200 million, and significantly increased operating cash flow by $74 million to $132 million.
- Cresco Labs Inc (CRLBF) maintained its number one market share position in key states like Illinois, Pennsylvania, and Massachusetts, and achieved share growth in Ohio.
- The company is strategically expanding its footprint by reinforcing core markets and entering new markets like Kentucky, which offers favorable regulatory structures.
- Cresco Labs Inc (CRLBF) demonstrated strong retail performance, with its dispensaries being 30% more productive than the average store in their markets.
- The company faced price compression in core markets, which limited its ability to fully capitalize on increased demand in Q4 2024.
- Wholesale revenue declined sequentially due to price compressions in Illinois and Pennsylvania, and supply constraints amplified pricing impact on revenue and margin.
- Cresco Labs Inc (CRLBF) anticipates near-term margin pressure as it ramps up production capacity in Illinois and Pennsylvania.
- The company is proactively limiting sales to customers with potential accounts receivable risk, which creates short-term headwinds.
- Cresco Labs Inc (CRLBF) expects continued pricing pressures and market fragmentation, particularly in Illinois, to weigh on revenue in the near term.
Hello everyone and thank you for standing by. Today's call will be beginning momentarily. We thank you for your patience.
Good day and welcome to Cresco Labs fourth quarter 2024 earnings conference call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the call over to TJ Cole, Senior Vice President, Corporate Development and Investor Relations for Cresco Labs. Please go ahead.
Thank you. Good morning. Welcome to Cresco Lab's fourth quarter 2024 earnings conference call. On the call today, we have Chief Executive Officer and co-founder Charles Bachtell; Chief Financial Officer, Sharon Schuler; and President, Greg Butler, who will be available to the Q&A.
Prior to this call, we issued our fourth quarter earnings press release, which has been filed on SEDAR and is available on our investor relations website. These preliminary results for the fourth quarter and full year 2024 are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
